6fvh: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
'''Unreleased structure'''


The entry 6fvh is ON HOLD  until Mar 02 2020
==Macrophage Migration Inhibitory Factor (MIF) with Covalently Bound PITC==
 
<StructureSection load='6fvh' size='340' side='right' caption='[[6fvh]], [[Resolution|resolution]] 1.40&Aring;' scene=''>
Authors: Samygina, V.R., Bourenkov, G., Sokolov, A.V.
== Structural highlights ==
 
<table><tr><td colspan='2'>[[6fvh]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6FVH OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6FVH FirstGlance]. <br>
Description: Macrophage Migration Inhibitory Factor (MIF) with Covalently Bound PITC
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=0FI:N-PHENYLTHIOFORMAMIDE'>0FI</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
[[Category: Unreleased Structures]]
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6fvh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6fvh OCA], [http://pdbe.org/6fvh PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6fvh RCSB], [http://www.ebi.ac.uk/pdbsum/6fvh PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6fvh ProSAT]</span></td></tr>
[[Category: Sokolov, A.V]]
</table>
[[Category: Samygina, V.R]]
== Disease ==
[[http://www.uniprot.org/uniprot/MIF_HUMAN MIF_HUMAN]] Genetic variations in MIF are associated with susceptibility to rheumatoid arthritis systemic juvenile (RASJ) [MIM:[http://omim.org/entry/604302 604302]]. An inflammatory articular disorder with systemic-onset beginning before the age of 16. It represents a subgroup of juvenile arthritis associated with severe extraarticular features and occasionally fatal complications. During active phases of the disorder, patients display a typical daily spiking fever, an evanescent macular rash, lymphadenopathy, hepatosplenomegaly, serositis, myalgia and arthritis.
== Function ==
[[http://www.uniprot.org/uniprot/MIF_HUMAN MIF_HUMAN]] Pro-inflammatory cytokine. Involved in the innate immune response to bacterial pathogens. The expression of MIF at sites of inflammation suggests a role as mediator in regulating the function of macrophages in host defense. Counteracts the anti-inflammatory activity of glucocorticoids. Has phenylpyruvate tautomerase and dopachrome tautomerase activity (in vitro), but the physiological substrate is not known. It is not clear whether the tautomerase activity has any physiological relevance, and whether it is important for cytokine activity.<ref>PMID:15908412</ref> <ref>PMID:17443469</ref> 
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Bourenkov, G]]
[[Category: Bourenkov, G]]
[[Category: Samygina, V R]]
[[Category: Sokolov, A V]]
[[Category: Isomerase]]
[[Category: Isomerase inhibitor]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA